Library
2-TFMXP
2-TFMXP is classified as Dissociative NMDA‑receptor antagonist. It belongs to the Arylcyclohexylamine (diphenidine/diarylethylamine family) chemical class.
Also known as: 2‑TFM‑MXP, TFMXP, 2‑трифторометил‑MXP, 2‑TFM‑дифенидин
Classification
- Chemical: Diarylethylamine
- Psychoactive: Dissociative
Effects
- Somatic Lightness
- Pain Relief
- Stimulation
- Incoordination
- Impaired Balance
- Numbness
- Time Dilation
- Dissociation
- Euphoria
- Memory Impairment
- Foggy Thinking
- Disconnection
- Closed Eye Visuals
- Open Eye Visuals
- Patterning
- Warping
- Ringing
- Auditory Distortion
Routes of Administration
Oral
Dosage
- Heavy: 70 mg+ (NOT RECOMMENDED)
- Light: 10–25 mg
- Common: 25–45 mg
- Strong: 45–70 mg
- Threshold: 5–10 mg
Duration
- Onset: 0.33-1 h
- Peak: 1.5-4 h
- Offset: 4-8 h
- After Effects: 8-24 h
- Total Duration: 6-10 h
Sublingual
Dosage
- Heavy: 60 mg+ (NOT RECOMMENDED)
- Light: 8–20 mg
- Common: 20–40 mg
- Strong: 40–60 mg
- Threshold: 4–8 mg
Duration
- Onset: 0.17-0.67 h
- Peak: 1.25-3.5 h
- Offset: 3.5-8 h
- After Effects: 8-24 h
- Total Duration: 6-10 h
Insufflated
Dosage
- Heavy: 45 mg+ (NOT RECOMMENDED)
- Light: 5–15 mg
- Common: 15–30 mg
- Strong: 30–45 mg
- Threshold: 3–5 mg
Duration
- Onset: 0.08-0.25 h
- Peak: 1-3 h
- Offset: 3-6.5 h
- After Effects: 6.5-24 h
- Total Duration: 5-9 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
No external data sources listed for this substance yet.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
